RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Khosrow Kashfi to Drug Screening Assays, Antitumor

This is a "connection" page, showing publications Khosrow Kashfi has written about Drug Screening Assays, Antitumor.
  1. Vannini F, MacKessack-Leitch AC, Eschbach EK, Chattopadhyay M, Kodela R, Kashfi K. Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid. Bioorg Med Chem Lett. 2015 Oct 15; 25(20):4677-82.
    View in: PubMed
    Score: 0.114
  2. Kashfi K. Anti-cancer activity of new designer hydrogen sulfide-donating hybrids. Antioxid Redox Signal. 2014 Feb 10; 20(5):831-46.
    View in: PubMed
    Score: 0.098
  3. Kaur K, Enders P, Zhu Y, Bratton AF, Powell CR, Kashfi K, Matson JB. Amino acid-based H2S donors: N-thiocarboxyanhydrides that release H2S with innocuous byproducts. Chem Commun (Camb). 2021 Jun 03; 57(45):5522-5525.
    View in: PubMed
    Score: 0.043
  4. Tabatabaei Dakhili SA, P?rez DJ, Gopal K, Haque M, Ussher JR, Kashfi K, Vel?zquez-Mart?nez CA. SP1-independent inhibition of FOXM1 by modified thiazolidinediones. Eur J Med Chem. 2021 Jan 01; 209:112902.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support